Registration Document

Overview

The report is GenSight Biologics' Registration Document covering its 2015 financial year and comparative 2014 information. It describes the ongoing Phase III RESCUE and REVERSE trials for GS010 and the preclinical optogenetics program for GS030. The company reported 25 employees at December 31, 2015 and identified sustainable development as a priority focused on cost reduction, energy savings and increasingly compliant operations.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2015
Period: Ends 31 December 2015
Publication date: 24 May 2016
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services